In the closing of the recent trading day, Teladoc (TDOC) stood at $6, denoting a +1.35% move from the preceding trading day.
TDOC expands Solo with AI tools that streamline virtual assessments and clinical documentation, targeting simpler workflows for hospitals.
The latest trading day saw Teladoc (TDOC) settling at $5.56, representing a -3.64% change from its previous close.
Teladoc (TDOC) concluded the recent trading session at $6.28, signifying a -2.33% move from its prior day's close.
Teladoc Health trades near multi-year lows, with the market pricing in deep distress despite meaningful free cash flow and manageable debt. BetterHelp's rapid decline drags on TDOC, but Integrated Care's improving margins and growing revenue per member offer stabilization. TDOC's valuation is extremely depressed, trading at just 7–8x expected free cash flow, with fair value estimates suggesting significant upside even under conservative scenarios.
Teladoc (TDOC) reached $6.16 at the closing of the latest trading day, reflecting a +1.15% change compared to its last close.
TDOC's Integrated Care is driving profitability as chronic care gains traction, potentially making it the company's key earnings driver.
Teladoc Health's growth is supported by chronic care, international expansion and Teladoc One, but BetterHelp weakness and losses temper the outlook.
Teladoc (TDOC) reported earnings 30 days ago. What's next for the stock?
TDOC's BetterHelp faces a capacity crunch as insurance demand surges, putting therapist recruitment and credentialing at the center.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
TDOC tops adjusted earnings estimates despite a revenue miss, as Integrated Care and international growth help cushion BetterHelp weakness and a lower 2026 outlook.